[PDF] Top 20 DEVELOPMENT AND EVALUATION OF IRBESARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN
Has 10000 "DEVELOPMENT AND EVALUATION OF IRBESARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN" found on our website. Below are the top 20 most common "DEVELOPMENT AND EVALUATION OF IRBESARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN".
DEVELOPMENT AND EVALUATION OF IRBESARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN
... factorial design to achieve NLT 85% dissolution in 10 ...For optimization of Irbesartan tablets as per 2 2 factorial design, βCD and Crospovidone are considered as the ... See full document
9
OPTIMIZATION OF IRBESARTAN TABLET FORMULATION EMPLOYING ?CD AND CROSPOVIDONE BY 22 FACTORIAL DESIGNS
... of irbesartan in its formulation ...is optimization of irbesartan tablet formulation employing Crospovidone and βCD by 2 2 factorial ...of irbesartan tablets (i) with NLT 85% ... See full document
9
FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN
... mg) tablets were prepared by direct compression method as per the formula given in Table ...Micromeritic evaluation of the blends was made by determining angle of repose (θ) and compressibility index ... See full document
9
FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN, IN VITRO AND PHARMACOKINETIC EVALUATION
... Dissolution rate of valsartan tablets prepared was studied in phosphate buffer of pH 6.8 (900 ml) employing eight station dissolution rate test apparatus (LABINDIA, DS 8000) using paddle stirrer at 50 rpm and at a ... See full document
12
Development of Liquisolid Tablets of Chlorpromazine using 32 Full Factorial Design
... process development time is through the design of the ...for optimization of liquisolid tablets of chlorpromazine, grid searches were conducted to find the composition of optimized ...the ... See full document
8
OPTIMIZATION OF EFAVIRENZ TABLET FORMULATION EMPLOYING ? CD AND SOLUPLUS BY 22 FACTORIAL DESIGN
... formulation development. The objective of the present study is optimization of efavirenz tablet formulation employing βCD and Soluplus by 2 2 factorial ...efavirenz tablets with NLT 85% ... See full document
9
STUDIES ON FORMULATION OF DOXAZOSIN MESYLATE TABLETS USING CROSCARAMELLOSE SODIUM AND SODIUM DODECYL SULFATE OPTIMIZATION BY 22 FACTORIAL DESIGN
... formulation development to derive its maximum therapeutic ...2 factorial design to achieve NLT 85% dissolution in 15 ...For optimization of Doxazosin Mesilate tablets as per 2 2 ... See full document
12
Formulation development and optimization of fast orodispersible tablets of naratriptan hydrochloride by using factorial design
... Orodispersible Tablets: Each ingredient was passed through #60 mesh sieve ...The tablets were prepared by direct compression technique 8,9 . Optimization of Super Disintegrating Agent: Oral fast ... See full document
6
DEVELOPMENT AND OPTIMIZATION OF ITOPRIDE HYDROCHLORIDE FAST DISINTEGRATING TABLETS USING FACTORIAL DESIGN AND RESPONSE SURFACE METHODOLOGY
... time. Tablets containing SSG disintegrate due to the rapid uptake of water, followed by rapid and enormous swelling into primary ...disintegrating tablets 22 ... See full document
12
Development of Fast Dissolving Tablets of Bisoprolol Fumarate and Statistical Optimization by Using 32 Factorial Design.
... ordinary tablets may not allow precise measurement of the disintegration time of FDTs because of their fast ...for evaluation of the disintegration time; however, no additional information might be ...the ... See full document
119
FORMULATION OF RITONAVIR TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN
... formulation development. The objective of the present study is optimization of ritonavir tablet formulation employing βCD and Soluplus by 2 2 factorial ...ritonavir tablets with NLT 85% ... See full document
9
FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN
... is development of oral controlled release tablets of Lamivudine employing a combination of hydrophilic polymer, HPMC K 100M and hydrophobic polymer, ethyl cellulose using 2 2 factorial ...matrix ... See full document
9
FORMULATION AND EVALUATION OF CAPTOPRIL FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN
... formulation optimization techniques is relatively new to the practice of ...The optimization procedure is facilitated by applying factorial designs and by the fitting of an empirical polynomial ... See full document
13
A STUDY ON FEASIBILITY OF OPTIMIZATION TECHNIQUE IN FORMULATION OF DISPERSIBLE TABLETS BY FACTORIAL DESIGN
... the development of dispersible tablet by using various super ...an optimization technique was ...numerical optimization by desirability function was performed with desired ...the optimization ... See full document
20
FORMULATION DEVELOPMENT AND EVALUATION OF LAMOTRIGINE SUSTAINED RELEASE TABLETS USING 32 FACTORIAL DESIGN
... The In-vitro dissolution study for the lamotrigine sustained release tablets were carried out in USP XXIII type-II dissolution test apparatus (Paddle type) using 900 ml of 0.1 N HCl as dissolution medium for 12 ... See full document
7
DESIGN CHARACTERIZATION AND OPTIMIZATION OF ORALLY DISINTEGRATING TABLETS OF SITAGLIPTIN USING 32 FACTORIAL DESIGN
... disintegrating tablets, namely SSG (X1) and Natural disintegrant (X2) concentrations using a statistical package (Design Exper, version ...the factorial design is represented in Table ...This ... See full document
11
FORMULATION AND EVALUATION OF IRBESARTAN IMMEDIATE RELEASE TABLETS
... The solubility of irbesartan in phosphate buffer pH 6.8 and pH 7.4 was determined by the phase equilibrium method. An excess amount of drug was taken into 50 ml conical flasks containing 20 ml of phosphate buffers ... See full document
6
ENHANCEMENT OF SOLUBILITY OF EFAVIRENZ EMPLOYING ? CD AND SLS: OPTIMIZATION BY 22 FACTORIAL DESIGN
... (i)Solution with a solubility of 260 mg of efavirenz per 100ml could be prepared employing β CD at 10.5mM and SLS at4.32% concentrations (solution 1) .(ii) Solution with a solubility of 200 mg of efavirenz per 100 ml ... See full document
6
Fabrication and Evaluation of Floating Mucoadhesive Tablets of Cefpodoxime Proxetil Using Factorial Design
... mucoadhesive tablets of cefpodoxime proxetil , so as to remain in the gastric region for several hours and hence significantly prolong the gastric residence time of drugs which improve ... See full document
14
FORMULATION AND OPTIMIZATION OF LIQUISOLID TABLETS OF OLMESARTAN MEDOXOMIL USING 32 FACTORIAL DESIGN
... 2 Factorial Design: From the comparative study of carriers, avicel and neusilin, neusilin was selected for further optimization ...2 factorial design was employed for the preparation of ... See full document
12
Related subjects